1-2 of 2
Francesco Autore
Close
Sort by
Journal Articles

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

Alberto Fresa, Francesco Autore, Alfonso Piciocchi, Gioacchino Catania, Andrea Visentin, Annamaria Tomasso, Marina Moretti, Candida Vitale, Annalisa Chiarenza, Francesca Morelli, Paolo Sportoletti, Roberto Marasca, Giuseppe Sapienza, Annarosa Cuccaro, Roberta Murru, Alessandro Sanna, Caterina Patti, Ilaria Angeletti, Marta Coscia, Livio Trentin, Daniela Pietrasanta, Idanna Innocenti, Luca Laurenti
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3875–3878.
https://doi.org/10.1182/bloodadvances.2022006964
Published: 2022
Includes: Supplemental data
Journal Articles

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy

Clinical Trials & Observations
Fabio Efficace, Uwe Platzbecker, Massimo Breccia, Francesco Cottone, Paola Carluccio, Prassede Salutari, Eros Di Bona, Erika Borlenghi, Francesco Autore, Luciano Levato, Olimpia Finizio, Valentina Mancini, Stefano D’Ardia, Richard F. Schlenk, Lorella Melillo, Monica Fumagalli, Walter Fiedler, Germana Beltrami, Nicola Stefano Fracchiolla, Massimo Bernardi, Paola Fazi, Ombretta Annibali, Karin Mayer, Maria Teresa Voso, Marco Vignetti
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4370–4379.
https://doi.org/10.1182/bloodadvances.2021004649
Published: 2021
Includes: Supplemental data